5-45695870-TCGCCGCCGCCGCCGCCGC-TCGCCGCCGCCGCCGC
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PM4_SupportingBP6BS1BS2
The NM_021072.4(HCN1):c.221_223del(p.Gly74del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000631 in 1,544,546 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 0 hom. )
Consequence
HCN1
NM_021072.4 inframe_deletion
NM_021072.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.52
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_021072.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 5-45695870-TCGC-T is Benign according to our data. Variant chr5-45695870-TCGC-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 581499.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000371 (55/148098) while in subpopulation AFR AF= 0.00127 (51/40300). AF 95% confidence interval is 0.000989. There are 0 homozygotes in gnomad4. There are 24 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 55 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HCN1 | NM_021072.4 | c.221_223del | p.Gly74del | inframe_deletion | 1/8 | ENST00000303230.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HCN1 | ENST00000303230.6 | c.221_223del | p.Gly74del | inframe_deletion | 1/8 | 1 | NM_021072.4 | P2 | |
HCN1 | ENST00000634658.1 | c.221_223del | p.Gly74del | inframe_deletion | 1/2 | 3 | |||
HCN1 | ENST00000673735.1 | c.221_223del | p.Gly74del | inframe_deletion | 1/9 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000365 AC: 54AN: 147980Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
54
AN:
147980
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00362 AC: 595AN: 164440Hom.: 0 AF XY: 0.00310 AC XY: 289AN XY: 93110
GnomAD3 exomes
AF:
AC:
595
AN:
164440
Hom.:
AF XY:
AC XY:
289
AN XY:
93110
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000659 AC: 920AN: 1396448Hom.: 0 AF XY: 0.000654 AC XY: 453AN XY: 692868
GnomAD4 exome
AF:
AC:
920
AN:
1396448
Hom.:
AF XY:
AC XY:
453
AN XY:
692868
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000371 AC: 55AN: 148098Hom.: 0 Cov.: 32 AF XY: 0.000332 AC XY: 24AN XY: 72336
GnomAD4 genome
AF:
AC:
55
AN:
148098
Hom.:
Cov.:
32
AF XY:
AC XY:
24
AN XY:
72336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 24;C5193120:Generalized epilepsy with febrile seizures plus, type 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | HCN1 NM_021072.3 exon 1 p.Gly74del (c.221_223del): This variant has not been reported in the literature and is present in 0.5% (79/13482) of East Asian alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/5-45695972-TCGC-T). This variant is present in ClinVar (Variation ID:581449). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant represents an in-frame deletion of one amino acid at position 74, which is within a repeat region, and it is not predicted to alter the reading frame. However, the effect of this variant on the protein is unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Dec 16, 2023 | - - |
Developmental and epileptic encephalopathy, 24 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at